Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma

Saudi Journal of Gastroenterology

Volumn 14, Issue 2, 2008, Pages 90-92

  Al Kalbani, Abdullah ^a   Kamel, Yasser ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Hepatocellular carcinoma; Radioembolization; Y 90 microspheres

Indexed keywords

EID: 42149143532     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.39627     Document Type: Article

References (16)

1. Feldman. Sleisenger and Fordtran's Gastrointestinal and LiverDisease, 8th ed. Chapter 19
2. Salem R, et al. Yttriuin-90 microspheres for the treatment of hepatocellular carcinoma: A review. Int J Radiat Oncol. Biol Phys 2006;66:S83-8.
3. Llovet J, et al. Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): Results of a Phase III randomized placebo-controlled trial (SHARP trial). Proceedings from the American Society of Clinical Oncology Conference: Chicago, IL; 2007.
4. Goin JE, Salem R, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities. J Vasc Interv Radiol 2005;16:205-13.
5. Salem R, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response and survival. J Vasc Interv Radiol 2005;16:1627-39.
6. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A riskstratification analysis. J Vasc Interv Radiol 2005;16:195-203.
7. Ravi Murthy, et al. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations and potential complications. Radiographics 2005;25:S41-55.
8. Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolisation of yttrium-90 microspheres. Biomed Imaging Interv J 2006;2:e43.
9. Kulik LM, et al. Emerging approaches in hepatocellular carcinoma. J Clin Gastroenterol 2007;41:839-54.
10. Kulik LM, et al. Safety and efficacy of 90y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008;47:1.
11. Salem R, et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004;15:335-45.
12. Goin J, Dancey JE, Roberts C, et al. Comparison of postembolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: Trans-catheter chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 2004;3:49-56.
13. Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004;127:S194-205.
14. Sangro B, Bilbao JI, Boan J, et al. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;66:792-800.
15. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-7.
16. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 2006;17:1251-78.